Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Bamboo Therapeutics Inc.

Headquarters: Chapel Hill, NC, United States of America
Website: N/A
Year Founded: 2014
Status: Acquired

BioCentury | Sep 21, 2022
Product Development

How venture philanthropy is driving modality innovation for DMD

Targeted antisense and non-viral gene therapies top CureDuchenne’s technology priority list
BioCentury | Oct 26, 2020
Deals

Bayer’s $2B deal for AskBio follows biotech’s decision to bet on its own pipeline

Deal gives Bayer gene therapy programs, manufacturing and technologies
BioCentury | Apr 12, 2019
Finance

AskBio answers investors’ call

Why AskBio finally took venture money to invest in its own gene therapy pipeline
BioCentury | Apr 11, 2019
Financial News

TPG, Vida back Asklepios in $235M round

BioCentury | Aug 31, 2018
Clinical News

Pfizer ends Phase II trials of DMD candidate

BioCentury | Aug 30, 2018
Clinical News

Pfizer ends Phase II trials of DMD candidate

BioCentury | Feb 2, 2018
Product Development

AA Viral meme

James Wilson’s findings on AAV toxicity should have limited impact on the vectors’ use in humans
Items per page:
1 - 10 of 18